{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:18:58Z","timestamp":1771834738452,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rmed.2026.108695","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:00:59Z","timestamp":1770253259000},"page":"108695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The bacterial lysate OM-85 reduces exacerbations and oral corticosteroid use in frequently exacerbating patients with T2-High asthma: The OMREXA real-world evidence study"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-5022","authenticated-orcid":false,"given":"Maria Elpida","family":"Christopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia S.","family":"Panteli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John \u0391.","family":"Moisidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis A.","family":"Christopoulos I","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia S.","family":"Tryphonidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios I.","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108695_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02865-2021","article-title":"The burden of asthma, hay fever and eczema in adults in 17 countries: GAN phase I study","volume":"60","author":"Mortimer","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108695_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108695_bib3","series-title":"Global Strategy for Asthma Management and Prevention","year":"2024"},{"key":"10.1016\/j.rmed.2026.108695_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American thoracic society\/european respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108695_bib5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/thoraxjnl-2015-208138","article-title":"Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model","volume":"71","author":"Loymans","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2026.108695_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaci.2009.07.035","volume":"124","author":"Haselkorn","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.108695_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1398-9995.2007.01394.x","article-title":"Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations","volume":"62","author":"Dusser","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.108695_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.coi.2006.09.002","article-title":"Mechanisms of the hygiene hypothesis \u2014 molecular and otherwise","volume":"18","author":"Vercelli","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.rmed.2026.108695_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","article-title":"The microbiota of the respiratory tract: gatekeeper to respiratory health","volume":"15","author":"Man","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.rmed.2026.108695_bib10","first-page":"200","article-title":"Non-specific immune stimulation in respiratory tract infections. Separating the wheat from the chaff","volume":"15","author":"Feleszko","year":"2014","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.108695_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2106720","article-title":"Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: a Delphi study","volume":"18","author":"Esposito","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.rmed.2026.108695_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137135","article-title":"Broncho-Vaxom Attenuates lipopolysaccharide-induced inflammation in a mouse model of Acute lung injury","volume":"25","author":"Woo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2026.108695_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188010","article-title":"Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1\/2 mitogen activated protein kinase and cAMP","volume":"12","author":"Roth","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2026.108695_bib14","series-title":"Frontiers in Immunology","article-title":"Airway administration of bacterial lysate OM-85 protects mice against respiratory syncytial virus infection","author":"Antunes","year":"2022"},{"key":"10.1016\/j.rmed.2026.108695_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2021.11.019","article-title":"The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression","volume":"149","author":"Pivniouk","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2026.108695_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111544","article-title":"OM-85 Broncho-Vaxom(\u00ae), a bacterial lysate, reduces SARS-CoV-2 binding proteins on human bronchial epithelial cells","volume":"9","author":"Fang","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.rmed.2026.108695_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep43844","article-title":"OM-85 is an immunomodulator of interferon-\u03b2 production and inflammasome activity","volume":"7","author":"Dang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2026.108695_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/mi.2010.43","article-title":"Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control","volume":"4","author":"Strickland","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.rmed.2026.108695_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.9734\/BJMMR\/2014\/4458","article-title":"The effect of the oral bacterial extract OM-85 BV on asthma control - a prospective study","volume":"4","author":"Christopoulos","year":"2014","journal-title":"Br. J. Med. Med. Res."},{"key":"10.1016\/j.rmed.2026.108695_bib20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcph.518","article-title":"Effects of OM-85 BV in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"55","author":"Pan","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2026.108695_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1183\/09031936.94.07030446","article-title":"Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis","volume":"7","author":"Orcel","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.108695_bib22","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","volume":"156","author":"Collet","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108695_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000093933","article-title":"Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease","volume":"74","author":"Sol\u00e8r","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2026.108695_bib24","first-page":"153","article-title":"Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study","volume":"51","author":"Tielemans","year":"1999","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.rmed.2026.108695_bib25","article-title":"A meta-analysis on the efficacy and safety of bacterial lysates in chronic obstructive pulmonary disease","volume":"9","author":"Huang","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2026.108695_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00408-016-9880-5","article-title":"Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections","volume":"194","author":"Koatz","year":"2016","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2026.108695_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2147\/JAA.S517194","article-title":"Oral bacterial lysate OM-85 prevents respiratory tract infections in asthma: the OMRIA RWE Study","volume":"18","author":"Christopoulou","year":"2025","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.rmed.2026.108695_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108695_bib29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00705-012-1576-4","article-title":"Characterisation of winter respiratory viral infections in patients with asthma and COPD in Qatar","volume":"158","author":"Althani","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.rmed.2026.108695_bib30","article-title":"Vulnerability for respiratory infections in asthma patients: a systematic review","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rmed.2026.108695_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.anai.2015.02.008","article-title":"Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma","volume":"114","author":"Kearney","year":"2015","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2026.108695_bib32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/cea.13990","article-title":"Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: a double-blind placebo-controlled trial","volume":"51","author":"de Boer","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2026.108695_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(10)61380-3","article-title":"Role of viral respiratory infections in asthma and asthma exacerbations","volume":"376","author":"Busse","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108695_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbagen.2011.01.012","article-title":"Viruses and asthma","volume":"1810","author":"Dulek","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.rmed.2026.108695_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/bmj.307.6910.982","article-title":"Respiratory viruses and exacerbations of asthma in adults","volume":"307","author":"Nicholson","year":"1993","journal-title":"Br. Med. J."},{"key":"10.1016\/j.rmed.2026.108695_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bjid.2015.03.004","article-title":"Asthma exacerbation and viral infection in adult patients, Brazil","volume":"19","author":"Silva","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"issue":"Suppl","key":"10.1016\/j.rmed.2026.108695_bib37","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1378\/chest.63.4_Supplement.44S-a","article-title":"Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis","volume":"63","author":"Horn","year":"1973","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2026.108695_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(02)07953-9","article-title":"Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study","volume":"359","author":"Corne","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108695_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0272-5231(05)70268-9","article-title":"The role of bacterial infections in asthma","volume":"21","author":"Kraft","year":"2000","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2026.108695_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23725","article-title":"Exploring the risk of infection events in patients with asthma receiving anti-IL-5 monoclonal antibodies: a rapid systematic review and a meta-analysis","volume":"10","author":"Giossi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.rmed.2026.108695_bib42","series-title":"European Respiratory & Pulmonary Diseases","article-title":"Immunomodulation therapy \u2013 clinical relevance of bacterial lysates OM-85","author":"Rossi","year":"2019"},{"key":"10.1016\/j.rmed.2026.108695_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12519-010-0001-x","article-title":"OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review","volume":"6","author":"Schaad","year":"2010","journal-title":"World J Pediatr"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:52:16Z","timestamp":1771833136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S0954611126000636"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108695","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bacterial lysate OM-85 reduces exacerbations and oral corticosteroid use in frequently exacerbating patients with T2-High asthma: The OMREXA real-world evidence study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108695"}}